Articles by Erin Slifka

Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.

XPeng’s second-quarter net loss narrowed on stronger sales, higher revenue from its collaboration with Volkswagen and improved margins.

Activist investor Icahn agrees to pay $500,000 and his company will pay $1.5 million, without admitting or denying SEC findings.

Seven & i received the acquisition offer from Alimentation Couche-Tard following pressure on activist shareholders to improve the Japanese company’s profitability.

Fabrizio Freda will retire next year and the beauty company says its board is searching for its next leader.

The move affects the company’s software and services division.

As Elon Musk awaits Beijing’s green light, Chinese EV makers sell models that can cruise without intervention on city streets.

Companies are redoing the math behind the green-energy transition amid the rise of AI data centers.

New Cybertruck owners have posted on social media about getting vehicles with dirt on the inside and spots on the outside.

The more you share, the greater the risk to security and privacy. But lying can also cause problems.